参考文献/References:
[1]夏志远, 周萍, 刘亦悦,等. 国际新兴卫生技术评估经验及启示[J].中国卫生质量管理,2016,23(1):91-95.
相似文献/References:
[1]林伟龙邓明梁锌甘蓝霞杨娟王惠杨谨成杨文静.2017年-2019年我国三级公立医院肿瘤住院患者医疗服务与质量安全分析[J].中国卫生质量管理,2022,29(11):001.[doi:10.13912/j.cnki.chqm.2022.29.11.01
]
LIN Weilong,DENG Ming,LIANG Xin.Analysis on Medical Service and Quality Safety of Tumor Inpatients in Chinese Tertiary Public Hospitals from 2017 to 2019[J].Chinese Health Quality Management,2022,29(06):001.[doi:10.13912/j.cnki.chqm.2022.29.11.01
]
[2]邓明时黎明林伟龙杨谨成安宇杨娟周成诚杨文静.我国肿瘤单病种质控路径实践与展望[J].中国卫生质量管理,2022,29(11):006.[doi:10.13912/j.cnki.chqm.2022.29.11.02
]
DENG Ming,SHI Liming,LIN Weilong.Practice and Prospect of Quality Control Path of Single Disease of Tumor in China[J].Chinese Health Quality Management,2022,29(06):006.[doi:10.13912/j.cnki.chqm.2022.29.11.02
]
[3]邓明林伟龙安宇杨娟杨文静.关于肿瘤治疗前临床TNM分期评估的思考[J].中国卫生质量管理,2022,29(11):009.[doi:10.13912/j.cnki.chqm.2022.29.11.03
]
DENG Ming,LIN Weilong,AN Yu.Consideration on Clinical TNM Stage Evaluation before Tumor Treatment[J].Chinese Health Quality Management,2022,29(06):009.[doi:10.13912/j.cnki.chqm.2022.29.11.03
]
[4]林伟龙王惠杨文静.我国肿瘤专业医疗质量控制中心建设现状调查[J].中国卫生质量管理,2024,31(02):035.[doi:10.13912/j.cnki.chqm.2024.31.2.09]
LIN Weilong,WANG Hui,YANG Wenjing.The Construction of Tumor Professional Medical Quality Control Center in China: a Cross-Sectional Study[J].Chinese Health Quality Management,2024,31(06):035.[doi:10.13912/j.cnki.chqm.2024.31.2.09]